APA (7th ed.) Citation

Gelineau, N. U., Bozsaky, E., van Zogchel, L. M. J., Rifatbegovic, F., Lazic, D., Ziegler, A., . . . Taschner-Mandl, S. (2025). Sensitive detection of minimal residual disease and immunotherapy targets by multi-modal bone marrow analysis in high-risk neuroblastoma – a multi-center study. Journal of Experimental & Clinical Cancer Research (17569966), 44(1), 1. https://doi.org/10.1186/s13046-025-03481-w

Chicago Style (17th ed.) Citation

Gelineau, Nina U., et al. "Sensitive Detection of Minimal Residual Disease and Immunotherapy Targets by Multi-modal Bone Marrow Analysis in High-risk Neuroblastoma – a Multi-center Study." Journal of Experimental & Clinical Cancer Research (17569966) 44, no. 1 (2025): 1. https://doi.org/10.1186/s13046-025-03481-w.

MLA (9th ed.) Citation

Gelineau, Nina U., et al. "Sensitive Detection of Minimal Residual Disease and Immunotherapy Targets by Multi-modal Bone Marrow Analysis in High-risk Neuroblastoma – a Multi-center Study." Journal of Experimental & Clinical Cancer Research (17569966), vol. 44, no. 1, 2025, p. 1, https://doi.org/10.1186/s13046-025-03481-w.